Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
B2 Thymoma · Thymic Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China